Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
MgShell S.r.l. logo — La sfida che ci proponiamo è quella di rivoluzionare complet...

MgShell S.r.l.

La sfida che ci proponiamo è quella di rivoluzionare completamente l'approccio terapeutico nel campo oftalmico.

Founded 2019 Italy Italy 5 employees Seed Total: $500.00K Health Care, Manufacturing +1

General Information

Company Name MgShell S.r.l.
Founded Year 2019
Location Italy Italy
Founders / Decision Makers
Team member Team member
Employees 5
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with MgShell S.r.l.. To contact MgShell S.r.l., visit mgshell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MgShell S.r.l. compare?

A PDF of MgShell S.r.l. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MgShell S.r.l. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MgShell S.r.l.

MgShell is an Italian startup founded in 2019, aiming to revolutionize the therapeutic approach in the field of ophthalmology. The company addresses the challenges associated with age-related macular degeneration, a chronic ocular disease and a leading cause of blindness in developed countries. With 500,000 new cases per year and an estimated 260 million affected patients by 2040, there is a pressing need for effective solutions. The current clinical strategy involves monthly intravitreal injections, which often result in a high rate of treatment dropout and pose a significant risk of irreversible blindness. In response, MgShell is developing an innovative intraocular device that aims to significantly reduce the number of injections and therapeutical burdens. This device represents a technological breakthrough, offering the ability to replicate the current clinical practice with a single injection, release therapeutic drug doses autonomously, and eliminate the need for surgical procedures. The latest milestone for MgShell was a €500.00K Seed Round investment on 26 January 2023, with financial backing from Club degli Investitori, Bios Line Holding, and Italian Angels for Biotech. The company operates in the Health Care and Manufacturing industries. MgShell's business model not only aims to improve compliance for affected patients but also seeks to reduce overheads for healthcare systems and create opportunities for pharmaceutical companies.

Business keywords: Ophthalmic healthcare, Medical devices, Innovation, Therapeutic technology, Macular degeneration, Intraocular device, Drug delivery system, Pharmaceutical industry, Compliance solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €500.00K 3
Club degli Investitori Bios Line Holding Italian Angels for Biotech
Club degli Investitori, Bios Line Holding +1
26 Jan 2023
Seed Round Undisclosed 1
PoliHub
01 Mar 2021

MgShell S.r.l. Alternatives & Competitors

View All Alternatives
MgShell S.r.l. vs
Nova Oculus
Nova Oculus

Experience gentle, drug-free relief for age-related macular degeneration with advanced microcurrent...

Seed
Health Care, Health and Wellness
MgShell S.r.l. vs
Rheon Medical
Rheon Medical Switzerland

Rheon focuses on the development, manufacturing and marketing of first-in-class glaucoma drainage de...

Debt Financing
7 employees
Health Care, Health and Wellness
MgShell S.r.l. vs
Softhale
Softhale

Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices

Series A
Biotechnology, Health Care
View all alternatives

FAQ About MgShell S.r.l.

La sfida che ci proponiamo è quella di rivoluzionare completamente l'approccio terapeutico nel campo oftalmico.
MgShell S.r.l. was founded in 2019.
MgShell S.r.l. is headquartered in Italy.
MgShell S.r.l. operates in Health Care, Manufacturing and Medical Devices. Its work centres on Ophthalmic healthcare, Medical devices, Innovation and Therapeutic technology.
MgShell S.r.l. has approximately 5 employees.
MgShell S.r.l. has completed 2 funding rounds, raising a total of $500.00K. The latest funding stage is Seed.
Top alternatives and competitors to MgShell S.r.l. include Nova Oculus, Rheon Medical, Softhale, VISION CARE CENTER LIMITED, Breath Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MgShell S.r.l. and Nova Oculus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MgShell S.r.l., https://bouncewatch.com/company/mgshell, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes